MedPath

Comparative Analgesic Effects of Paracetamol/Codeine and Ibuprofen on Pain After Third Molar Surgery

Phase 4
Completed
Conditions
To Control Pain After Third Molar Surgery
Interventions
Registration Number
NCT04730297
Lead Sponsor
University of Roma La Sapienza
Brief Summary

To compare analgesic effects of preoperative administration of paracetamol 500 milligram plus codeine 30 milligram in single-tablet and effervescent formulation to ibuprofen 400 milligram, and placebo in the management of moderate to severe postoperative pain after mandibular third molar surgery.

Detailed Description

Materials and methods: One hundred twenty healthy outpatients aged 15 to 29 years undergoing surgical removal of one bony impacted mandibular third molar were enrolled in this, single-center, prospective, randomized, triple-blind parallel-group, placebo-controlled, clinical trial. Study participants were randomly assigned to three treatment arms. According to the concealed allocation, each patient 30 minutes before surgery received paracetamol 500 mg plus codeine 30 mg (group A), ibuprofen 400 mg (group B) or placebo (group C). Rescue therapy allowed in the postoperative period was paracetamol 500 mg plus codeine 30 mg in groups A and C and ibuprofen 400 mg in group B. Patients recorded on Numerical Rating Scale-11 (NRS-11) the pain intensity, total number of postoperative-supplement medications and time of the first intake, until 12-hours after surgery and over extra two days

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • healthy status (ASA class I);
  • nonsmoker;
  • not pregnant or breastfeeding;
  • no medication consumption in the past 21 days;
  • good oral hygiene;
  • bony impaction of one mandibular third molars;
  • the presence of the first and second molars;
  • compliance to cooperate with the research protocol.
Exclusion Criteria
  • chronic systemic disease;
  • medications with potential interaction to paracetamol-codeine or ibuprofen;
  • a history of intolerance or hypersensitivity to the study drugs;
  • any pre-existing pain and acute inflammatory or infectious conditions; - inability to understand or perform the study procedure.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Paracetamol/codeine Group Aparacetamol 500 mg plus codeine 30 mg preoperative administrationanalgesic group preoperative oral dose of paracetamol 500 mg plus codeine 30 mg
Ibuprofen Group Bibuprofen 400 mg preoperative administrationanalgesic group preoperative oral dose of ibuprofen 400 mg
Placebo Group CPlacebo oral tablet preoperative administrationPlacebo group preoperative placebo
Primary Outcome Measures
NameTimeMethod
Pain measurement assessed with the Numerical Rating Scale-11 (NRS-11)All study participants were asked to record the pain intensity score at 11:00 pm during the 3th day after surgery]

In stage 1, the objective was to compare the efficacy on pain and tolerability of a single dose of paracetamol plus codeine, ibuprofen, or placebo in the operative day.

Secondary Outcome Measures
NameTimeMethod
Number of patients requiring rescue therapyuntil 12-hours after surgery and over extra two days

outcomes involved the number of patients requiring rescue therapy

first postoperative use of analgesicsuntil 12-hours after surgery

time of the first intake

total postoperative use of analgesicsuntil 12-hours after surgery and over extra two days

total amount of additional medication

Trial Locations

Locations (1)

Maria Paola Cristalli

🇮🇹

Roma, Italy

© Copyright 2025. All Rights Reserved by MedPath